secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sensei Biotherapeutics, Inc. (SNSE)
CIK:        0001829802
Form:       8-K
Filed at:   2025-06-13T23:59:59+00:00
Accession:  0001193125-25-140329
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sensei Biotherapeutics announces 1-for-20 reverse stock split effective June 16
-------------------------------------------------------------------------------

- Reverse stock split at 1-for-20 ratio effective 5:00 p.m. ET on June 16, 2025.
- Authorized shares reduced from 250,000,000 to 12,500,000; par value unchanged.
- No fractional shares issued; stockholders receive cash payment in lieu.
- Common stock trades on split-adjusted basis on Nasdaq Capital Market starting June 17, 2025.
- Outstanding stock options, RSUs, and warrants proportionately adjusted.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1829802/000119312525140329/0001193125-25-140329-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1829802/000119312525140329/d945713d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-140329

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer